280 related articles for article (PubMed ID: 25442764)
41. [The Gougerot-Sjögren syndrome].
Hatron PY; Delesalle JC; Lacroix G; Gosset D; Vinckier L; Devulder B
Rev Prat; 1986 Apr; 36(23):1287-98. PubMed ID: 3715349
[No Abstract] [Full Text] [Related]
42. [Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine].
Ponge T; Mussini JM; Ponge A; Forgeau Y; Barrier J; Cottin S; Grolleau JY
Rev Neurol (Paris); 1987; 143(2):147-8. PubMed ID: 3602794
[TBL] [Abstract][Full Text] [Related]
43. Immune cytopenias as the presenting finding in primary Sjögren's syndrome.
Schattner A; Friedman J; Klepfish A; Berrebi A
QJM; 2000 Dec; 93(12):825-9. PubMed ID: 11110590
[TBL] [Abstract][Full Text] [Related]
44. Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.
Gottenberg JE; Ravaud P; Puéchal X; Le Guern V; Sibilia J; Goeb V; Larroche C; Dubost JJ; Rist S; Saraux A; Devauchelle-Pensec V; Morel J; Hayem G; Hatron P; Perdriger A; Sene D; Zarnitsky C; Batouche D; Furlan V; Benessiano J; Perrodeau E; Seror R; Mariette X
JAMA; 2014 Jul; 312(3):249-58. PubMed ID: 25027140
[TBL] [Abstract][Full Text] [Related]
45. Peyronie's disease in a patient with primary Sjögren's syndrome.
Kobak S; Saraçoğlu M
Int J Rheum Dis; 2014 Jan; 17(1):116-7. PubMed ID: 24472275
[No Abstract] [Full Text] [Related]
46. Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.
Ju UH; Liu FC; Lin CS; Huang WY; Lin TY; Shen CH; Chou YC; Lin CL; Lin KT; Kao CH; Chen CH; Yang TY
Medicine (Baltimore); 2019 Apr; 98(14):e14984. PubMed ID: 30946325
[TBL] [Abstract][Full Text] [Related]
47. Type II cryoglobulinaemic vasculitis with primary Sjögren's syndrome successfully treated with belimumab and hydroxychloroquine.
Izuka S; Yamashita H; Takahashi Y; Kaneko H
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):223-224. PubMed ID: 33666157
[No Abstract] [Full Text] [Related]
48. Tocilizumab for refractory organising pneumonia associated with Sjögren's disease.
Justet A; Ottaviani S; Dieudé P; Taillé C
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976199
[TBL] [Abstract][Full Text] [Related]
49. A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature.
Soy M; Pamuk ON; Gerenli M; Celik Y
Rheumatol Int; 2005 Nov; 26(1):86-9. PubMed ID: 15690142
[TBL] [Abstract][Full Text] [Related]
50. Hydroxycholoroquine-induced hyperpigmentation.
Mir A; Boyd KP; Meehan SA; McLellan B
Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
[TBL] [Abstract][Full Text] [Related]
51. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.
Wang SQ; Zhang LW; Wei P; Hua H
BMC Musculoskelet Disord; 2017 May; 18(1):186. PubMed ID: 28499370
[TBL] [Abstract][Full Text] [Related]
52. Primary Sjogren syndrome.
Ramos-Casals M; Brito-Zerón P; Sisó-Almirall A; Bosch X
BMJ; 2012 Jun; 344():e3821. PubMed ID: 22700787
[No Abstract] [Full Text] [Related]
53. Critical hypokalemic renal tubular acidosis due to Sjögren's syndrome: association with the purported immune stimulant echinacea.
Logan JL; Ahmed J
Clin Rheumatol; 2003 May; 22(2):158-9. PubMed ID: 12740687
[No Abstract] [Full Text] [Related]
54. Primary Sjögren syndrome that developed after IgA nephropathy.
Ito S; Kamei K; Ikoma M
Pediatr Nephrol; 2010 Aug; 25(8):1579-80. PubMed ID: 20309585
[No Abstract] [Full Text] [Related]
55. Idiopathic CD4+ lymphocytopenia and Sjogren syndrome.
Wladis EJ; Kapila R; Chu DS
Arch Ophthalmol; 2005 Jul; 123(7):1012. PubMed ID: 16009850
[No Abstract] [Full Text] [Related]
56. First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.
Nikiphorou E; Hall FC
Rheumatology (Oxford); 2014 Oct; 53(10):1906-7. PubMed ID: 24729401
[No Abstract] [Full Text] [Related]
57. Occurrence of rheumatoid arthritis requiring oral and/or biological disease-modifying antirheumatic drug therapy following a diagnosis of primary Sjögren syndrome.
Khan O; Carsons S
J Clin Rheumatol; 2012 Oct; 18(7):356-8. PubMed ID: 23013848
[TBL] [Abstract][Full Text] [Related]
58. Primary Sjogren syndrome diagnosed simultaneously with localized amyloidosis of the lacrimal gland: A case report.
Kweon SM; Koh JH; Lee HN; Kim E; So MW; Shin HJ; Young Choi H; Lee SG
Medicine (Baltimore); 2018 Jun; 97(23):e11014. PubMed ID: 29879064
[TBL] [Abstract][Full Text] [Related]
59. Hypokalemic paralysis as primary presentation of Fanconi syndrome associated with Sjögren syndrome.
Wang CC; Shiang JC; Huang WT; Lin SH
J Clin Rheumatol; 2010 Jun; 16(4):178-80. PubMed ID: 20414123
[TBL] [Abstract][Full Text] [Related]
60. Autoimmune hepatitis concomitant with hypergammaglobulinemic purpura, immune thrombocytopenia, and Sjögren's syndrome.
Wada M; Kamimoto H; Park SY; Shintani S; Nakasho K
Intern Med; 2001 Apr; 40(4):308-11. PubMed ID: 11334390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
